Blueprint Medicines Corp.

NAS: BPMC

GO
/marketstate/country/us

After Hours

/zigman2/quotes/209215354/composite

$

62.83

Change

0.00 0.00%

Volume

Volume 12,875

Oct 6, 2022, 4:27 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209215354/composite

Previous close

$ 65.00

$ 62.83

Change

-2.17 -3.34%

Day low

Day high

$62.76

$65.00

Open
Open: 64.48

52 week low

52 week high

$43.46

$117.86

Open

Market cap

$3.75B

Average volume

847,879

P/E ratio

N/A

Rev. per Employee

$465,632

EPS

-11.87

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/bpmc

MarketWatch News on BPMC

  1. Blueprint Medicines started at outperform with $80 stock price target at Oppenheimer

    7:37 a.m. July 8, 2022

    - Tomi Kilgore

  2. Biotech Stocks Finally Rose in June. What Does It Mean?

    9:07 a.m. July 1, 2022

    - Barron's Online

  3. Blueprint Medicines upgraded to buy from hold at Stifel Nicolaus

    12:36 p.m. Jan. 25, 2022

    - Tomi Kilgore

  4. Blueprint Medicines coverage resumed at Stifel with hold stock rating and $105 target price

    7:07 a.m. Sept. 30, 2021

    - Tonya Garcia

  5. Blueprint Medicines started at hold with $110 stock price target at Stifel Nicolaus

    9:00 a.m. Dec. 3, 2020

    - Tomi Kilgore

  6. Here Are Stocks That Benefit Under Different Election Outcomes

    12:26 p.m. Oct. 20, 2020

    - Barron's Online

  7. The Pandemic Speeds Up the Health-Care Revolution

    6:01 p.m. Oct. 6, 2020

    - Barron's Online

  8. Blueprint Medicines shares gain on deal with Roche

    8:28 a.m. July 14, 2020

    - Jaimy Lee

  9. Roche, Blueprint to co-develop lung-cancer drug

    2:18 a.m. July 14, 2020

    - MarketWatch.com

  10. 7 Biotech Stocks to Buy for a Post-Pandemic World

    10:48 p.m. Aug. 17, 2020

    - Barron's Online

  11. Blueprint Medicines upgraded to outperform at BMO Capital

    8:37 a.m. March 17, 2020

    - Tomi Kilgore

  12. Blueprint Medicines upgraded to buy from hold at Deutsche Bank

    7:26 a.m. March 17, 2020

    - Tomi Kilgore

  13. Blueprint Medicines started at market perform at BMO Capital

    10:16 a.m. Jan. 28, 2020

    - Tomi Kilgore

  14. A Biotech Veteran Thinks He Can Undersell the Entire Drug Industry

    1:19 p.m. Jan. 12, 2020

    - Barron's Online

  15. Blueprint prices new cancer drug at $32,000 per month

    9:49 a.m. Jan. 10, 2020

    - Jaimy Lee

  16. Blueprint Medicines reiterated as buy at Canaccord

    3:02 p.m. Dec. 10, 2019

    - Ciara Linnane

  17. Blueprint Medicines upgraded to strong buy from outperform at Raymond James

    9:28 a.m. Nov. 6, 2019

    - Tomi Kilgore

  18. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/bpmc

Other News on BPMC

  1. Will Ayvakit Aid Blueprint Medicines (BPMC) Amid Rivalry?

    11:10 a.m. Oct. 5, 2022

    - Zacks.com

  2. Deciphera (DCPH) Rises 90% in the Past 6 Months: Here's Why

    10:20 a.m. Sept. 30, 2022

    - Zacks.com

  3. IDNA: Healthcare Dashboard For August

    6:19 p.m. Aug. 16, 2022

    - Seeking Alpha

  4. Loading more headlines...
/news/pressrelease/company/us/bpmc

Press Releases on BPMC

  1. Tuesday Sector Leaders: Oil & Gas Refining & Marketing, Drugs

    12:24 p.m. Aug. 2, 2022

    - MarketNewsVideo.com

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.